JTC Membership Program
Advancing thyroid cancer research through collaborative publication excellence.
Uniting the Thyroid Cancer Research Community
The Journal of Thyroid Cancer membership program connects clinicians, researchers, and specialists dedicated to advancing understanding, diagnosis, and treatment of thyroid malignancies.
Members gain reduced publication costs, priority review processing, and access to a global network of thyroid oncology professionals working to improve patient outcomes worldwide.
Individual Researcher
- 15% discount on article processing charges
- Priority peer review processing
- Full access to JTC archive
- Quarterly research digest newsletter
- Member directory listing
- Digital membership certificate
Institutional Partner
- 25% discount on APCs for affiliated authors
- Expedited review for institutional submissions
- Unlimited researcher coverage
- Dedicated institutional liaison
- Annual publication metrics report
- Featured institution profile
- Priority special issue consideration
Lifetime Fellow
- 30% lifetime APC discount
- Fast-track manuscript review
- Editorial board invitation consideration
- Speaking opportunities at JTC events
- Recognition in fellows directory
- Complimentary language editing
Accelerated Publication
Fast-track your thyroid cancer research from submission to publication. Priority processing ensures your clinical findings and molecular discoveries reach oncologists and endocrinologists without delays.
Research Investment
Significant APC savings across all membership tiers allow you to redirect resources toward clinical trials, laboratory investigations, and patient care rather than publication expenses.
Global Network
Connect with thyroid oncologists, endocrine surgeons, nuclear medicine specialists, and molecular pathologists worldwide. Share insights across differentiated and anaplastic thyroid cancer research.
Professional Recognition
Demonstrate your commitment to advancing thyroid cancer knowledge. Fellows may be invited to contribute expert perspectives on emerging diagnostics and therapeutic developments.
Joining the JTC community is straightforward. Email [email protected] with your professional credentials, institutional affiliation, research specialty, and preferred membership tier. Our team reviews applications within 5 business days and provides activation credentials upon approval. Cancer centers and institutional partners receive personalized onboarding to maximize benefits across their thyroid oncology research teams.
Developing Nation Support: Thyroid cancer researchers from low and middle-income countries may qualify for reduced membership fees. JTC is committed to ensuring that economic barriers do not prevent clinician-scientists from emerging economies from accessing publication benefits and contributing to global thyroid oncology advancement.
ManuscriptZone Portal
Submit through oap.manuscriptzone.net for comprehensive manuscript tracking, reviewer communication, and revision management throughout the editorial process.
Simple Submission Form
Use our streamlined online form for rapid manuscript upload when you need a direct submission pathway for your thyroid cancer research.
JTC membership supports research across thyroid malignancy disciplines including papillary thyroid carcinoma, follicular thyroid cancer, medullary thyroid carcinoma, anaplastic thyroid cancer, thyroid cancer genetics, radioactive iodine therapy, targeted therapies, thyroidectomy outcomes, and survivor quality of life. Members publishing research on any aspect of thyroid oncology receive full tier benefits.
Membership status never influences editorial decisions. All member submissions undergo identical peer review scrutiny by thyroid cancer experts and must meet the same rigorous standards as non-member manuscripts. JTC maintains complete editorial independence, ensuring publication decisions rest solely on scientific merit and clinical relevance.
Thyroid cancer management requires multidisciplinary expertise spanning endocrinology, oncology, surgery, nuclear medicine, and pathology. JTC membership facilitates connections across these specialties, strengthening collaborative research approaches that translate into improved patient care.
Members gain opportunities to engage with emerging clinical trial networks advancing thyroid cancer therapeutics. From novel targeted agents to combination therapies, membership connects researchers with the evolving landscape of thyroid cancer treatment innovation.
JTC recognizes the importance of patient perspectives in research direction. Members contribute to publishing research that directly addresses patient concerns including quality of life, treatment side effects, and survivorship issues that matter most to those affected by thyroid malignancies.
Join the Thyroid Oncology Community
Partner with researchers worldwide dedicated to improving thyroid cancer outcomes.